페니트리움바이오 반기보고서 (2024.06)
1. 요약재무정보

1) 요약연결재무정보(단위: 원)

구분	제23기 당 반기말 (2024년 06월말)	제22기 전기말 (2023년 12월말)	제21기 전전기말 (2022년 12월말)

[유동자산]	25,816,867,583	25,555,266,153	40,589,451,279

ㆍ현금및현금성자산	18,453,518,604	3,372,575,210	3,097,124,698

ㆍ단기금융상품	2,055,978,885	15,601,000,000	24,000,000,000

ㆍ당기손익-공정가치측정금융자산	-	-	7,972,804,866

ㆍ매출채권및기타채권	4,220,886,744	4,829,834,701	3,985,136,066

ㆍ재고자산	120,740,448	1,162,854,413	402,481,233

ㆍ기타유동자산	965,742,902	589,001,829	1,131,904,416

[비유동자산]	18,053,163,455	18,658,927,574	5,702,953,933

ㆍ관계기업투자주식	888,184,558	871,971,044	952,060,316

ㆍ당기손익-공정가치측정비유동금융자산	1,019,373,400	974,520,000	224,364,912

ㆍ유형자산	2,606,105,963	2,849,220,036	2,792,157,646

ㆍ무형자산	1,033,343,191	1,081,519,184	973,401,615

ㆍ투자부동산	11,616,721,245	11,720,483,348	-

ㆍ기타비유동자산	889,435,098	1,161,213,962	760,969,444

자산총계	43,870,031,038	44,214,193,727	46,292,405,212

[유동부채]	29,206,981,228	15,296,655,852	14,207,021,960

[비유동부채]	1,819,209,182	1,789,955,526	1,375,585,374

부채 총계	31,026,190,410	17,086,611,378	15,582,607,334

지배기업소유주지분	13,195,889,744	27,150,789,792	30,340,609,792

[자본금]	2,183,625,000	2,183,625,000	2,183,625,000

[자본잉여금]	20,418,648,438	20,418,648,438	20,418,648,438

[기타자본]	(3,719,693,353)	(3,727,813,651)	(3,723,279,478)

[이익잉여금]	(5,686,690,341)	8,276,330,005	11,461,615,832

비지배지분	(352,049,116)	(23,207,443)	369,188,086

자본 총계	12,843,840,628	27,127,582,349	30,709,797,878

관계기업 투자주식의 평가방법	지분법	지분법	지분법

2024.01.01~2024.06.30	2023.01.01~2023.12.31	2022.01.01~2022.12.31

매출액	5,559,110,117	13,790,195,699	14,882,555,787

영업이익	(12,338,876,128)	(3,464,613,885)	(754,740,449)

당기순이익	(14,214,386,550)	(3,363,294,388)	(58,882,743)

지배기업소유주지분	(13,876,181,561)	(2,970,313,225)	266,502,935

비지배지분	(338,204,989)	(392,981,163)	(325,385,678)

주당순이익	(656)	(140)	12

희석주당이익	(455)	(87)	3

2) 요약재무정보(단위: 원)

구분	제23기 당 반기말 (2024년 06월말)	제22기 전기말 (2023년 12월말)	제21기 전전기말 (2022년 12월말)

[유동자산]	25,587,932,184	26,416,763,716	39,845,619,438

ㆍ현금및현금성자산	18,423,936,287	3,326,420,831	3,084,101,544

ㆍ단기금융상품	2,055,978,885	15,601,000,000	24,000,000,000

ㆍ당기손익-공정가치측정금융자산	-	-	7,972,804,866

ㆍ매출채권및기타채권	4,196,893,285	6,775,291,022	3,726,662,122

ㆍ기타유동자산	911,123,727	714,051,863	1,062,050,906

[비유동자산]	15,788,132,732	18,179,783,943	7,078,266,068

ㆍ당기손익-공정가치측정비유동금융자산	1,019,373,400	974,520,000	224,364,912

ㆍ종속기업투자주식	-	1,907,636,272	3,815,272,544

ㆍ관계기업투자주식	743,773,620	743,773,620	743,773,620

ㆍ유형자산	1,307,401,789	1,368,990,257	1,461,088,871

ㆍ무형자산	271,445,405	266,663,505	64,383,068

ㆍ투자부동산	11,616,721,245	11,720,483,348	-

ㆍ기타비유동자산	829,417,273	1,197,716,941	769,383,053

자산총계	41,376,064,916	44,596,547,659	46,923,885,506

[유동부채]	29,035,486,158	15,144,738,418	13,934,446,459

[비유동부채]	682,884,709	661,875,854	182,535,087

부채 총계	29,718,370,867	15,806,614,272	14,116,981,546

[자본금]	2,183,625,000	2,183,625,000	2,183,625,000

[자본잉여금]	21,395,991,395	21,395,991,395	21,395,991,395

[기타자본]	(3,739,155,755)	(3,739,155,755)	(3,739,155,755)

[이익잉여금]	(8,182,766,591)	8,949,472,747	12,966,443,320

자본 총계	11,657,694,049	28,789,933,387	32,806,903,960

종속,관계투자주식의 평가방법	원가법	원가법	원가법

2024.01.01~2024.06.30	2023.01.01~2023.12.31	2022.01.01~2022.12.31

매출액	5,283,744,847	13,790,195,699	14,881,305,787

영업이익	(11,771,505,565)	(1,911,004,834)	516,521,349

당기순이익	(17,016,470,432)	(3,800,188,519)	1,144,040,937

주당순이익	(804)	(180)	53

희석주당이익	(579)	(124)	42